imatinib amomed 100 mg film - coated tablets
amomed pharma gmbh - imatinib - 100 mg film - coated tablets
imatinib amomed 400 mg film - coated tablets
amomed pharma gmbh - imatinib - 400 mg film - coated tablets
imatinib actavis group 100 mg film - coated tablets
actavis group ptc ehf. - imatinib - 100 mg film - coated tablets
imatinib actavis group 400 mg film - coated tablets
actavis group ptc ehf. - imatinib - 400 mg film - coated tablets
imatinib cipla 100 mg capsules, hard
cipla europe nv - imatinib - 100 mg capsules, hard
imatinib cipla 100 mg capsules, hard
cipla europe nv - imatinib - 100 mg capsules, hard
imatinib zentiva 100 mg film - coated tablets
zentiva k.s. - imatinib - 100 mg film - coated tablets
imatinib teva pharma 400 mg film - coated tablets
Тева Фармасютикълс България ЕООД - imatinib - 400 mg film - coated tablets
imatinib teva pharma 100 mg film - coated tablets
Тева Фармасютикълс България ЕООД - imatinib - 100 mg film - coated tablets
sunitinib accord
accord healthcare s.l.u. - сунитиниб - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Антинеопластични средства - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.